Alligator Bioscience: Interview with CEO Søren Bregenholt (video)

Research Interview



Redeye interviewed CEO Søren Bregenholt about the IND approval for ALG.APV-527 and the new results from mitazalimab’s phase II trial published at the AACR.


Richard Ramanius

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.